7 mos in on tirzepatide, i’m looking back at my notes from when i was on semaglutide. the thing that stands out is how different the GI disruption was - on sema, it was mostly just nausea for the first month, but on tirz, it ran to week 11. and yeah, the appetite suppression is real on both, but i found it more consistent on tirz. i’m down to 130g protein min daily, which is actually easier to hit than i thought it’d be.
the ‘food noise’ is still there, but it’s way less of a thing than it was on sema. what’s interesting to me is how the glucose spikes differ - on sema, i’d get these tiny spikes after meals, but on tirz, it’s more like a slow roll. and the hot flashes… yeah, those are a thing on tirz, but not so much on sema.
i’ve been tracking them in my spreadsheet, and it’s wild to see the correlation between the flashes and my glucose levels. the monthly summary in CareClinic is actually really helpful for spotting those trends, btw. anyway, for anyone considering switching from sema to tirz, i’d say the biggest difference is just how much more… intense everything feels on tirz.
the appetite suppression, the GI disruption, the glucose control - it’s all just more pronounced. and for me, at least, it’s been worth it. my numbers are better, and i feel more in control of my diet. but hey, ymmv, right?
the hot flashes tracking with glucose is interesting, but falling leptin levels often signal the hypothalamus to lower your thermal set point, which is a separate mechanism from direct glucose shifts.
what you said about the ‘intensity’ of tirzepatide vs sema, that makes sense. feels like sometimes you just hit a different level of systemic impact with a new med. that happened to me with trying different C
that intensity you’re describing on tirz vs sema really resonates. the GI piece for sure, where nausea often lifts by week 5 but constipation can lag well into month four, just bc those are distinct signals on different timelines.
for the hot flashes, that correlation w/ glucose is a good observation. fwiw, sometimes what gets lumped as
the hot flashes tracking with glucose is interesting, but falling leptin levels often signal the hypothalamus to lower your thermal set point, separate from direct glucose fluctuations… tirzepatide’s deeper metabolic shifts definitely make everything feel more ‘on’ compared to sema, not just for appetite.
the monthly summary in careclinic is helpful, but for ‘hot flashes’ correlating w/ glucose, i’d wonder if your daily check-in includes a cycle phase option? that’s often the missing overlay, especially for women, that clarifies the signal. it can make an 11-week log of gi disruption read completely differently.
that wild correlation you found between flashes and glucose levels is exactly what i mean about the daily pattern work falling on us. it takes a real effort to track something like that and then connect the dots. the monthly summary in care